| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | erismodegib | CTRPv2 | pan-cancer | AAC | -0.0052 | 0.9 |
| mRNA | KU-55933 | GDSC1000 | pan-cancer | AAC | -0.0048 | 0.9 |
| mRNA | bid1870 | gCSI | pan-cancer | AAC | 0.0075 | 0.9 |
| mRNA | BRD-K79669418 | CTRPv2 | pan-cancer | AAC | 0.0067 | 0.9 |
| mRNA | masitinib | CTRPv2 | pan-cancer | AAC | 0.0046 | 0.9 |
| mRNA | Dasatinib | FIMM | pan-cancer | AAC | 0.023 | 0.9 |
| mRNA | Oxaliplatin | CTRPv2 | pan-cancer | AAC | 0.004 | 0.9 |
| mRNA | SR-II-138A | CTRPv2 | pan-cancer | AAC | 0.0038 | 0.9 |
| mRNA | QW-BI-011 | CTRPv2 | pan-cancer | AAC | 0.0081 | 0.9 |
| mRNA | Methotrexate | FIMM | pan-cancer | AAC | 0.018 | 0.9 |